Abstract:Objective: The study's objective involved compatibility studies to investigate the possible interactions between 5-fluorouracil (5-FU) and four different lipids, and the most appropriate lipid was chosen. Differential scanning calorimetry (DSC), X-ray diffraction (XRD), and Fourier Transform Infrared spectroscopy (FT-IR) are used for the compatibility study between 5-FU and several excipients as cholesterol, compritol®, stearic acid, and glycerol monostearate (GMS). Methods: The physical mixture between 5-FU and each lipid was made by mixing of a certain amount of drug with the same amount of lipid. Drug lipid blended mixtures were made by solvent evaporation casting method. 5-FU alone, physical mixture and blended mixture were measured using Differential scanning calorimetry (DSC) to investigate melting peak of drug and effect of each lipid on this melting point, X-ray diffraction (XRD) to observe the crystalline or amorphous state of drug and Fourier Transform Infrared (FT-IR) to determine any chemical interaction between drug and these lipids by observing any shift happened to characteristic peaks related to the drug. Results: 5-FU Tm (280.04 °C) peak appeared in drug-lipid physical mixtures with minor changes in position while this peak disappeared in 5-FU-compritol® and 5-FU-cholesterol blended mixture, indicating that the drug is molecular dispersed. XRD result showed that the crystalline structure of 5-FU was present in physical mixtures with four lipids, while in the 5-FU-compritol® blended mixture, the crystalline state of the drug was disappeared, confirming the DSC result. The FT-IR spectrum of the 5-FU-physical mixtures with four lipids showed that all characteristic peaks of the drug appeared with minor changes. In the case of 5-FU-blended mixtures with mentioned lipids, no chemical interaction occurred between the drug and mentioned lipids except in the drug-stearic acid blended mixture, the N-H peak at 3136.25 cm-1 was disappeared due to amide ester formation. Conclusion: The most appropriate lipids suitable for the preparation of 5-FU solid lipid nanoparticles were GMS and cholesterol.

Uniform Design Method Used in the Preparation of Liposomal 5-FU and the Stabilities

Optimization of Fabrication Parameters to Prepare Tea Catechin-Loaded Liposomes Using Response Surface Methodology

Response surface methodology for the optimization of lactoferrin nano-liposomes

Application of Uniform Design for Preparation of Breviscapine Liposomes

Response Surface Methodology for the Optimization of Beta-Lactoglobulin Nano-Liposomes

Optimization of Epirubicin Liposome Formulation Using Box-Behnken Experimental Design

Uniform Design Method for Optimizing Proportion of Prescription of Xiaozheng

Optimization of Breviscapin Sustainded Release Tablets by Mixture Uniform Design

Development of liposomes using formulation by design: Basics to recent advances

Comparison of Several Statistic Designs in the Development of Ligustrazine Hydrochloride(tmph) Sustained Release Formulations

Study on the Optimal Formulation and Preparation Conditions of Propranolol-loaded Transfersomes by Central Composite Design and Response Surface Method

Preparation and Characterization of Universal Liquid Proliposomes Encapsulating Water-soluble Efficacious Substances

In Situ Precipitation: a Novel Approach for Preparation of Iron-Oxide Magnetoliposomes.

PRE-FORMULATION STUDY ON 5-FLUOROURACIL AND CERTAIN LIPIDS FOR SOLID LIPID NANOPARTICLES PREPARATION

[Study on Optimization of Formulation and Preparation Process of Sinomenine Liposomes].

Rapid optimization of liposome characteristics using a combined microfluidics and design-of-experiment approach

Optimization of preparation technology of Vincristine Sulfate Liposomes by orthogonal test

Application of fuzzy analytical method in the optimization of liposome preparation by orthogonal experiments

Optimization of the Extraction Method for Fingerprint of Yaotongning Capsule Based on Uniform Design

Process optimization for microfluidic preparation of liposomes using food-grade components

A Systematic Approach for Liposome and Lipodisk Preclinical Formulation Development by Microfluidic Technology